Specklin
Jean-Luc Specklin, Kembs-Schaferhof FR
Patent application number | Description | Published |
---|---|---|
20110059946 | DUAL ACTION ANTIBIOTICS - The present invention relates to compounds of the Formula (I) that are useful antimicrobial agents and effective against a variety of multi-drug resistant bacteria: | 03-10-2011 |
Jean-Luc Specklin, Kembs FR
Patent application number | Description | Published |
---|---|---|
20090247578 | 5-HYDROXYMETHYL-OXAZOLIDIN-2-ONE-DERIVATIVES AND THEIR USES AS ANTIBACTERIALS - The invention relates to novel chimeric antibiotics of formula I | 10-01-2009 |
20100069376 | 5-HYDROXYMETHYL-OXAZOLIDIN-2-ONE ANTIBACTERIALS - The invention relates to novel chimeric antibiotics of formula I | 03-18-2010 |
20100222302 | Novel Antibacterial Compounds - The invention relates to novel chimeric antibiotics of formula I | 09-02-2010 |
Jean-Luc Specklin, Kembs-Schaeferhof FR
Patent application number | Description | Published |
---|---|---|
20090306389 | Intermediate products for producing oxazolidinone-quinolone hybrids - The present invention describes intermediates (ZP) for a novel and efficient synthesis of compounds in which the pharmacophores of quinolone and oxazolidinone are linked to one another by way of a chemically stable linker. | 12-10-2009 |
20120135961 | USE OF OXAZOLIDINONE-QUINOLINE HYBRID ANTIBIOTICS FOR THE TREATMENT OF ANTHRAX AND OTHER INFECTIONS - The present invention relates to the use of compounds, in which the pharmacophores of quinolone and oxazolidinone are chemically linked together through a linker that is stable under physiological conditions, for the treatment of anthrax and other infections. | 05-31-2012 |
20120142635 | OXAZOLIDINONE-QUINOLONE HYBRID ANTIBIOTICS - The present invention relates to compounds of the Formula (I) that are useful antimicrobial agents and effective against a variety of multi-drug resistant bacteria: | 06-07-2012 |
20120322766 | USE OF OXAZOLIDINONE-QUINOLINE HYBRID ANTIBIOTICS FOR THE TREATMENT OF ANTHRAX AND OTHER INFECTIONS - The present invention relates to the use of compounds, in which the pharmacophores of quinolone and oxazolidinone are chemically linked together through a linker that is stable under physiological conditions, for the treatment of anthrax and other infections. | 12-20-2012 |
20130296275 | OXAZOLIDINONE-QUINOLONE HYBRID ANTIBIOTICS - The present invention relates to compounds of the Formula (I) that are useful antimicrobial agents and effective against a variety of multi-drug resistant bacteria: | 11-07-2013 |